Tag: Biotechnology

Ajinomoto and Olon collaborate on peptide manufacturing

Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) and Olon S.p.A. are teaming up. This partnership seeks to change how we…

Taiho Pharma Exercises Exclusive License for Casdatifan

Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised its option to develop and, if…

Hinge Bio partners with Kyorin to Develop HB2198 in Japan

Hinge Bio, Inc., a private biotech firm that focuses on multispecific antibody medicines, announced a partnership with Kyorin…

CRISPR and Beyond: Japan’s Strategic Blueprint for the Future of Gene Editing

Gene editing is no longer a lab experiment sitting in the background. For Japan, it has become a…

FUJIFILM and argenx Extend Collaboration to U.S. Operations

FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding its partnership with argenx SE, an…

Verified Clinical Trials launches in Japan to curb duplicates

Verified Clinical Trials (VCT) is now operating in Japan. They teamed up with Medical Revolutions Japan (MRJ) and…

Chugai and Gero Join Forces on Aging Disease Therapies

Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero has announced a joint research and…

Actair® Promotion in Japan Transitions to CEOLIA Pharma

Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co., Ltd. CEOLIA announced a change in…

PRD Therapeutics Begins First Human Trial for PRD001

 PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is a new selective inhibitor of SOAT2.…

Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan

Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership. This deal aims to speed up…

Fujirebio Acquires PSG to Boost Biological Material Supply

H.U. Group Holdings Inc., through its wholly owned subsidiary Fujirebio Holdings, Inc. Fujirebio announced that its subsidiary, Fujirebio…

Nuevocor Raises US$45M in Series B for Cardiomyopathy

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, announced the successful completion of…

Join Our Community

Join Our Community